Description
MYSULTA 375 is an advanced oral antibiotic formulation combining Sultamicillin 375 mg (as Tosylate Dihydrate). Sultamicillin is a double prodrug of ampicillin and sulbactam, offering enhanced bioavailability and improved bacterial coverage. It is effective against a variety of gram-positive and gram-negative bacteria, making it ideal for respiratory, urinary, skin, and soft tissue infections.
Packaged in 10×10 Alu-Alu tablets, MYSULTA 375 ensures product stability, protection from moisture, and ease of dispensing for pharmacies and practitioners.
Uses:
-
Upper and lower respiratory tract infections
-
Urinary tract infections (UTIs)
-
Skin and soft tissue infections
-
Gynecological infections
-
ENT infections
Directions for Use:
-
As directed by your physician
-
Usually taken twice daily after meals
-
Complete the full course, even if symptoms improve early
Benefits:
-
Broad-spectrum antibacterial coverage
-
Enhanced oral bioavailability compared to ampicillin alone
-
Reduced frequency of gastrointestinal side effects
-
Suitable for outpatient and hospital-based treatment protocols
-
Durable Alu-Alu packaging for longer shelf life
Pharma Franchise & Third-Party Manufacturing:
MYSULTA 375 is a high-efficacy antibacterial product manufactured by Biophar Lifesciences Pvt. Ltd. It is available for PCD pharma franchise and third-party manufacturing pan-India. With proven quality standards, on-time logistics, and marketing support, MYSULTA 375 can boost your antibiotic range with a trusted molecule that doctors recommend.
Partner with Biophar Lifesciences and get access to cutting-edge antibiotics and full franchise support for growing your pharma business in your preferred territory.
